================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-K
                CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934



                        DATE OF REPORT: NOVEMBER 14, 2002


                             COLORADO MEDTECH, INC.
                             ----------------------
             (Exact name of registrant as specified in its charter)


<Table>
<Caption>
        COLORADO                              000-12471                          84-0731006
- ----------------------------               ----------------                  ------------------
                                                                       
(State or other jurisdiction               (Commission File                   I.R.S. Employer
     of incorporation)                         Number)                       Identification No.)
</Table>

                             4801 NORTH 63RD STREET
                             BOULDER, COLORADO 80301
                             -----------------------
          (Address, including zip code, of principal executive offices)


                                 (303) 530-2660
                                 --------------
                         (Registrant's telephone number,
                              including area code)


================================================================================






ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS

         (c) Exhibits.

<Table>
<Caption>
          No.     Description
         ----     -----------
               
         99.1     Investor and analyst presentation materials of the President
                  and Chief Executive Officer of Colorado MEDtech, Inc. used at
                  the November 14, 2002 annual meeting of shareholders and to be
                  used from time to time thereafter.
</Table>

ITEM 9. REGULATION FD DISCLOSURE

         On November 14, 2002, Colorado MEDtech, Inc. held its annual meeting of
shareholders. A copy of the presentation materials of the company's President
and Chief Executive Officer that were used at that meeting and which are to be
used from time to time thereafter is filed as Exhibit 99.1 hereto.



                                      -2-






                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

         DATED, this 14th day of November, 2002.


                                     COLORADO MEDTECH, INC.


                                     By: /s/ Peter J. Jensen
                                         --------------------------------------
                                         Peter J. Jensen
                                         Vice President


                                      -3-


                                 EXHIBIT INDEX


<Table>
<Caption>
          No.     Description
         ----     -----------
               
         99.1     Investor and analyst presentation materials of the President
                  and Chief Executive Officer of Colorado MEDtech, Inc. used at
                  the November 14, 2002 annual meeting of shareholders and to be
                  used from time to time thereafter.
</Table>